| Total (N=123) | TARD (n=50) | TaTME (n=73) | P-value |
---|---|---|---|---|
Recurrence, n (%) | Â | Â | Â | 0.607 |
 Negative | 105 (85.4) | 44 (88.0) | 61 (83.6) |  |
 Positive | 18 (14.6) | 6 (12.0) | 12 (16.4) |  |
  Lung | 6 (4.9) | 2 (4.0) | 4 (5.5) |  |
  Liver | 1 (0.8) | 0 (0) | 1 (1.4) |  |
  Liver+ local | 1 (0.8) | 0 (0) | 1 (1.4) |  |
  Lung + Liver | 1 (0.8) | 1 (2.0) | 0 (0) |  |
  Bone | 1 (0.8) | 0 (0) | 1 (1.4) |  |
  Para-aorta lymph node | 1 (0.8) | 0 (0) | 1 (1.4) |  |
  Lymph nodes in the pelvis | 5 (4.1) | 2 (4.0) | 3 (4.1) |  |
  Local | 1 (0.8) | 1 (2.0) | 0 (0) |  |
  Wound | 1 (0.8) | 0 (0) | 1 (1.4) |  |
The period until recurrencea, month (range) | 18.5 (4–41) | 17.5 (4-41) | 19 (4–32) | 0.778 |
Observation timea, day (range) | 1440 (69–4975) | 2900 (670–4975) | 1051 (69–2361) | <0.001 |